KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBIT Margin (2016 - 2026)

Merck has reported EBIT Margin over the past 18 years, most recently at 47.46% for Q1 2026.

  • Quarterly EBIT Margin fell 6345.0% to 47.46% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 8.41% through Mar 2026, down 1638.0% year-over-year, with the annual reading at 7.21% for FY2025, 19.0% down from the prior year.
  • EBIT Margin was 47.46% for Q1 2026 at Merck, down from 12.99% in the prior quarter.
  • Over five years, EBIT Margin peaked at 16.73% in Q3 2025 and troughed at 62.25% in Q2 2023.
  • The 5-year median for EBIT Margin is 0.06% (2024), against an average of 5.39%.
  • Year-over-year, EBIT Margin plummeted -6411bps in 2023 and then surged 7628bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 2.66% in 2022, then tumbled by -1430bps to 40.72% in 2023, then soared by 105bps to 2.19% in 2024, then plummeted by -694bps to 12.99% in 2025, then crashed by -265bps to 47.46% in 2026.
  • Per Business Quant, the three most recent readings for MRK's EBIT Margin are 47.46% (Q1 2026), 12.99% (Q4 2025), and 16.73% (Q3 2025).